The relevance of RT-PCR detection of disseminated tumour cells is hampered by the expression of markers regarded as tumour-specific in activated lymphocytes

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2671-2674

  Kowalewska, Magdalena ^a,b   Chechlińska, Magdalena ^a   Markowicz, Sergiusz ^a   Kober, Paulina ^a   Nowak, Radosława ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

Author keywords

Carbonic anhydrase 9 (CA9); Circulating tumour cell (CTC) markers; Epidermal growth factor receptor (EGFR); Mammaglobin (hMAM); Small breast epithelial mucin (SBEM); Squamous cell carcinoma antigen (SCCA)

Indexed keywords

CARBONATE DEHYDRATASE IX; EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMAGLOBIN; MOLECULAR MARKER; MUCIN; TUMOR ANTIGEN;

ARTICLE; CANCER CYTODIAGNOSIS; CONTROLLED STUDY; DISSEMINATED CANCER; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; LYMPHOCYTE ACTIVATION; MARKER GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

CELL LINE, TUMOR; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; NEOPLASM CIRCULATING CELLS; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 33750145581     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.05.036     Document Type: Article

References (21)

1. Zach O., and Lutz D. Tumor cell detection in peripheral blood and bone marrow. Curr Opin Oncol 18 (2006) 48-56
2. Sharma P., Sahni N.S., Tibshirani R., et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 7 (2005) R634-R644
3. Borre M., Nerstrom B., and Overgaard J. Erythrocyte sedimentation rate - a predictor of malignant potential in early prostate cancer. Acta Oncol 36 (1997) 689-694
4. Mahmoud F.A., and Rivera N.I. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4 (2002) 250-255
5. Rutkowski P., Kamińska J., Kowalska M., Ruka W., and Steffen J. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer 100 (2002) 463-471
6. Chechlińska M., Kamińska J., Kowalska M., Radziszewski J., and Steffen J. The origin of cytokines, soluble cytokine receptors and CA125 in ascitic fluids and sera of ovarian cancer patients. Tumor Biol 24 Suppl 1 (2003) 76
7. Kamińska J., Nowacki M.P., Kowalska M., et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I - an independent prognostic factor. Tumor Biol 26 (2005) 186-194
8. Kamińska J., Kowalska M., Kotowicz B., et al. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor. Oncology 70 (2006) 115-125
9. Miyazaki K., Shimada K., Katabuchi H., Arakane F., Arao S., and Okamura H. Activated (HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors. Gynecol Oncol 58 (1995) 362-367
10. Murri A.M., Bartlett J.M., Canney P.A., Doughty J.C., Wilson C., and McMillan D.C. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94 (2006) 227-230
11. Forrest L.M., McMillan D.C., McArdle C.S., Angerson W.J., Dagg K., and Scott H.R. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92 (2005) 1834-1836
12. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
13. Stenman J., Lintula S., Hotakainen K., Vartiainen J., Lehvaslaiho H., and Stenman U.H. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix. Int J Cancer 74 (1997) 75-80
14. De Luca A., Pignata S., Casamassimi A., et al. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay. Clin Cancer Res 6 (2000) 1439-1444
15. Grunewald K., Haun M., Fiegl M., et al. Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest 82 (2002) 1147-1153
16. Miksicek R.J., Myal Y., Watson P.H., Walker C., Murphy L.C., and Leygue E. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium. Cancer Res 62 (2002) 2736-2740
17. Kowalewska M., Radziszewski J., Kulik J., et al. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR. Int J Cancer 116 (2005) 957-962
18. Jung R., Kruger W., Hosch S., et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 78 (1998) 1194-1198
19. Krüger W.H., Jung R., Detlefsen B., et al. Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells. Med Oncol 18 (2001) 33-38
20. Ballestrero A., Garuti A., Bertolotto M., et al. Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br J Cancer 92 (2005) 1948-1952
21. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 17,357 9255 (2001) 539-545